Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. 2005

Kazuhiro Kondo, and Kazuo Chijiiwa, and Ichiro Makino, and Masahiro Kai, and Naoki Maehara, and Jiro Ohuchida, and Seiji Naganuma
First Department of Surgery, Faculty of Medicine, Miyazaki University, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.

OBJECTIVE Although most patients who receive hepatectomy for a solitary hepatocellular carcinoma (HCC) have a relatively fair result, some have a poor prognosis. The aim of this study was to evaluate the risk factors for early death after hepatectomy in patients with a solitary HCC. METHODS Eligible patients (n=110) who had undergone hepatectomy for solitary HCC between 1990 and 2002 and were able to be followed up for more than 2 years after the hepatectomy were divided into two groups, those who died of cancer recurrence within 2 years (early-death group; n=18) and those who survived for more than 2 years after the surgery (survival group; n=92). Risk factors for early death after liver resection were evaluated by univariate and multivariate analyses. RESULTS The gross tumor classification, tumor diameter, macroscopic portal vein invasion, microscopic growth pattern, microscopic vascular invasion (MVI), and the width of the surgical margin were significant (P<0.05) factors by univariate analysis. Multivariate analysis showed that the presence of MVI was an independent and significant risk factor for early death of recurrence. CONCLUSIONS Among patients with solitary HCC, the presence of MVI indicates a poor prognosis. These patients need adjuvant chemotherapy in the early period after hepatectomy.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Kazuhiro Kondo, and Kazuo Chijiiwa, and Ichiro Makino, and Masahiro Kai, and Naoki Maehara, and Jiro Ohuchida, and Seiji Naganuma
March 2018, Annals of surgical treatment and research,
Kazuhiro Kondo, and Kazuo Chijiiwa, and Ichiro Makino, and Masahiro Kai, and Naoki Maehara, and Jiro Ohuchida, and Seiji Naganuma
February 2019, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,
Kazuhiro Kondo, and Kazuo Chijiiwa, and Ichiro Makino, and Masahiro Kai, and Naoki Maehara, and Jiro Ohuchida, and Seiji Naganuma
January 2023, Journal of hepatocellular carcinoma,
Kazuhiro Kondo, and Kazuo Chijiiwa, and Ichiro Makino, and Masahiro Kai, and Naoki Maehara, and Jiro Ohuchida, and Seiji Naganuma
January 2004, Journal of surgical oncology,
Kazuhiro Kondo, and Kazuo Chijiiwa, and Ichiro Makino, and Masahiro Kai, and Naoki Maehara, and Jiro Ohuchida, and Seiji Naganuma
January 2023, Journal of hepatocellular carcinoma,
Kazuhiro Kondo, and Kazuo Chijiiwa, and Ichiro Makino, and Masahiro Kai, and Naoki Maehara, and Jiro Ohuchida, and Seiji Naganuma
September 2008, The Korean journal of hepatology,
Kazuhiro Kondo, and Kazuo Chijiiwa, and Ichiro Makino, and Masahiro Kai, and Naoki Maehara, and Jiro Ohuchida, and Seiji Naganuma
January 2013, The British journal of surgery,
Kazuhiro Kondo, and Kazuo Chijiiwa, and Ichiro Makino, and Masahiro Kai, and Naoki Maehara, and Jiro Ohuchida, and Seiji Naganuma
October 2004, World journal of surgery,
Kazuhiro Kondo, and Kazuo Chijiiwa, and Ichiro Makino, and Masahiro Kai, and Naoki Maehara, and Jiro Ohuchida, and Seiji Naganuma
December 2015, Surgery,
Kazuhiro Kondo, and Kazuo Chijiiwa, and Ichiro Makino, and Masahiro Kai, and Naoki Maehara, and Jiro Ohuchida, and Seiji Naganuma
May 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association,
Copied contents to your clipboard!